Cargando…

Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults

PURPOSE: This study aimed to conduct an economic evaluation of mindfulness-based cognitive therapy (MBCT) in healthy participants by performing cost-utility analysis (CUA) and cost-benefit analysis (CBA). PATIENTS AND METHODS: CUA was carried out from a healthcare sector perspective and CBA was from...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagaoka, Maki, Koreki, Akihiro, Kosugi, Teppei, Ninomiya, Akira, Mimura, Masaru, Sado, Mitsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364820/
https://www.ncbi.nlm.nih.gov/pubmed/37492861
http://dx.doi.org/10.2147/PRBM.S406347
_version_ 1785076923093745664
author Nagaoka, Maki
Koreki, Akihiro
Kosugi, Teppei
Ninomiya, Akira
Mimura, Masaru
Sado, Mitsuhiro
author_facet Nagaoka, Maki
Koreki, Akihiro
Kosugi, Teppei
Ninomiya, Akira
Mimura, Masaru
Sado, Mitsuhiro
author_sort Nagaoka, Maki
collection PubMed
description PURPOSE: This study aimed to conduct an economic evaluation of mindfulness-based cognitive therapy (MBCT) in healthy participants by performing cost-utility analysis (CUA) and cost-benefit analysis (CBA). PATIENTS AND METHODS: CUA was carried out from a healthcare sector perspective and CBA was from the employer’s perspective in parallel with a randomized controlled trial. Of the 90 healthy participants, 50 met the inclusion criteria and were randomized to the MBCT group (n = 25) or wait-list control group (n = 25). In the CUA, intervention costs and healthcare costs were included, while the mean difference in the change in quality-adjusted life years (QALYs) between the baseline and 16-week follow-up was used as an indicator of effect. Incremental cost-effectiveness ratio (ICER) was produced, and uncertainty was addressed using non-parametric bootstrapping with 5000 replications. In the CBA, the change in productivity losses was reflected as a benefit, while the costs included intervention and healthcare costs. The net monetary benefit was calculated, and uncertainty was handled with 5000 bootstrapping. Healthcare costs were measured with the self-report Health Service Use Inventory. The purchasing power parity in 2019 was used for currency conversion. RESULTS: In the CUA, incremental costs and QALYs were estimated at JPY 19,700 (USD 189) and 0.011, respectively. The ICER then became JPY 1,799,435 (USD 17,252). The probability of MBCT being cost-effective was 92.2% at the threshold of 30,000 UK pounds per QALY. The CBA revealed that MBCT resulted in increased costs (JPY 24,180) and improved work productivity (JPY 130,640), with a net monetary benefit of JPY 106,460 (USD 1021). The probability of the net monetary benefit being positive was 69.6%. CONCLUSION: The results suggested that MBCT may be more cost-effective from a healthcare sector perspective and may be cost-beneficial from the employer’s perspective.
format Online
Article
Text
id pubmed-10364820
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-103648202023-07-25 Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults Nagaoka, Maki Koreki, Akihiro Kosugi, Teppei Ninomiya, Akira Mimura, Masaru Sado, Mitsuhiro Psychol Res Behav Manag Original Research PURPOSE: This study aimed to conduct an economic evaluation of mindfulness-based cognitive therapy (MBCT) in healthy participants by performing cost-utility analysis (CUA) and cost-benefit analysis (CBA). PATIENTS AND METHODS: CUA was carried out from a healthcare sector perspective and CBA was from the employer’s perspective in parallel with a randomized controlled trial. Of the 90 healthy participants, 50 met the inclusion criteria and were randomized to the MBCT group (n = 25) or wait-list control group (n = 25). In the CUA, intervention costs and healthcare costs were included, while the mean difference in the change in quality-adjusted life years (QALYs) between the baseline and 16-week follow-up was used as an indicator of effect. Incremental cost-effectiveness ratio (ICER) was produced, and uncertainty was addressed using non-parametric bootstrapping with 5000 replications. In the CBA, the change in productivity losses was reflected as a benefit, while the costs included intervention and healthcare costs. The net monetary benefit was calculated, and uncertainty was handled with 5000 bootstrapping. Healthcare costs were measured with the self-report Health Service Use Inventory. The purchasing power parity in 2019 was used for currency conversion. RESULTS: In the CUA, incremental costs and QALYs were estimated at JPY 19,700 (USD 189) and 0.011, respectively. The ICER then became JPY 1,799,435 (USD 17,252). The probability of MBCT being cost-effective was 92.2% at the threshold of 30,000 UK pounds per QALY. The CBA revealed that MBCT resulted in increased costs (JPY 24,180) and improved work productivity (JPY 130,640), with a net monetary benefit of JPY 106,460 (USD 1021). The probability of the net monetary benefit being positive was 69.6%. CONCLUSION: The results suggested that MBCT may be more cost-effective from a healthcare sector perspective and may be cost-beneficial from the employer’s perspective. Dove 2023-07-20 /pmc/articles/PMC10364820/ /pubmed/37492861 http://dx.doi.org/10.2147/PRBM.S406347 Text en © 2023 Nagaoka et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Nagaoka, Maki
Koreki, Akihiro
Kosugi, Teppei
Ninomiya, Akira
Mimura, Masaru
Sado, Mitsuhiro
Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults
title Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults
title_full Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults
title_fullStr Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults
title_full_unstemmed Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults
title_short Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults
title_sort economic evaluation alongside a randomized controlled trial of mindfulness-based cognitive therapy in healthy adults
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364820/
https://www.ncbi.nlm.nih.gov/pubmed/37492861
http://dx.doi.org/10.2147/PRBM.S406347
work_keys_str_mv AT nagaokamaki economicevaluationalongsidearandomizedcontrolledtrialofmindfulnessbasedcognitivetherapyinhealthyadults
AT korekiakihiro economicevaluationalongsidearandomizedcontrolledtrialofmindfulnessbasedcognitivetherapyinhealthyadults
AT kosugiteppei economicevaluationalongsidearandomizedcontrolledtrialofmindfulnessbasedcognitivetherapyinhealthyadults
AT ninomiyaakira economicevaluationalongsidearandomizedcontrolledtrialofmindfulnessbasedcognitivetherapyinhealthyadults
AT mimuramasaru economicevaluationalongsidearandomizedcontrolledtrialofmindfulnessbasedcognitivetherapyinhealthyadults
AT sadomitsuhiro economicevaluationalongsidearandomizedcontrolledtrialofmindfulnessbasedcognitivetherapyinhealthyadults